Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate (Q46628196)

23 December 2017

title

Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate (English)

1 reference

23 December 2017

seasonal allergic rhinitis

1 reference

1 reference

1

Leonard Bielory

1 reference

23 December 2017

publication date

1 March 2008

1 reference

23 December 2017

Annals of Allergy, Asthma & Immunology

published in

1 reference

23 December 2017

volume

100

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

272-279

1 reference

23 December 2017

Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

Allergic rhinitis and its impact on asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

Economic and quality-of-life impact of seasonal allergic conjunctivitis in Oxfordshire.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

The economic and quality of life impact of seasonal allergic conjunctivitis in a Spanish setting.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

Mometasone furoate improves congestion in patients with moderate-to-severe seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

Triamcinolone acetonide Aqueous nasal spray in patients with seasonal ragweed allergic rhinitis: a placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

Neural integration and allergic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

Intranasal fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

Perennial rhinitis subjects have altered vascular, glandular, and neural responses to bradykinin nasal provocation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

Discontinuing nasal steroids might lower intraocular pressure in glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

The clinical efficacy of budesonide in hay fever treatment is dependent on topical nasal application

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

Mometasone furoate. A review of its intranasal use in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

Effects of intranasal glucocorticoids on endogenous glucocorticoid peripheral and central function

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

Effect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

Allergic diseases of the eye.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960453-X

7 January 2021

10.1016/S1081-1206(10)60453-X

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017